Literature DB >> 18676882

Penetration of chlorhexidine into human skin.

T J Karpanen1, T Worthington, B R Conway, A C Hilton, T S J Elliott, P A Lambert.   

Abstract

This study evaluated a model of skin permeation to determine the depth of delivery of chlorhexidine into full-thickness excised human skin following topical application of 2% (wt/vol) aqueous chlorhexidine digluconate. Skin permeation studies were performed on full-thickness human skin using Franz diffusion cells with exposure to chlorhexidine for 2 min, 30 min, and 24 h. The concentration of chlorhexidine extracted from skin sections was determined to a depth of 1,500 microm following serial sectioning of the skin using a microtome and analysis by high-performance liquid chromatography. Poor penetration of chlorhexidine into skin following 2-min and 30-min exposures to chlorhexidine was observed (0.157 +/- 0.047 and 0.077 +/- 0.015 microg/mg tissue within the top 100 microm), and levels of chlorhexidine were minimal at deeper skin depths (less than 0.002 microg/mg tissue below 300 microm). After 24 h of exposure, there was more chlorhexidine within the upper 100-microm sections (7.88 +/- 1.37 microg/mg tissue); however, the levels remained low (less than 1 microg/mg tissue) at depths below 300 microm. There was no detectable penetration through the full-thickness skin. The model presented in this study can be used to assess the permeation of antiseptic agents through various layers of skin in vitro. Aqueous chlorhexidine demonstrated poor permeation into the deeper layers of the skin, which may restrict the efficacy of skin antisepsis with this agent. This study lays the foundation for further research in adopting alternative strategies for enhanced skin antisepsis in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676882      PMCID: PMC2565868          DOI: 10.1128/AAC.00637-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Eradication of resident bacteria of normal human skin by antimicrobial ointment.

Authors:  J Owen Hendley; Kathleen M Ashe
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 2.  Diagnosis of central venous catheter related infection in adult patients.

Authors:  Tony Worthington; Tom S J Elliott
Journal:  J Infect       Date:  2005-08-19       Impact factor: 6.072

3.  Determination of the antibacterial efficacy of several antiseptics tested on skin by an 'ex-vivo' test.

Authors:  Syndie Messager; P A Goddard; P W Dettmar; J-Y Maillard
Journal:  J Med Microbiol       Date:  2001-03       Impact factor: 2.472

4.  Drug distribution in human skin using two different in vitro test systems: comparison with in vivo data.

Authors:  H Wagner; K H Kostka; C M Lehr; U F Schaefer
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

5.  In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin.

Authors:  K Cal; S Janicki; M Sznitowska
Journal:  Int J Pharm       Date:  2001-08-14       Impact factor: 5.875

6.  Comparison of in-vivo antibacterial activity of two skin disinfection procedures for insertion of peripheral catheters: povidone iodine versus chlorhexidine.

Authors:  O Traoré; F A Allaert; S Fournet-Fayard; J L Verrière; H Laveran
Journal:  J Hosp Infect       Date:  2000-02       Impact factor: 3.926

7.  Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant.

Authors:  D Adams; M Quayum; T Worthington; P Lambert; T Elliott
Journal:  J Hosp Infect       Date:  2005-10-10       Impact factor: 3.926

8.  Human skin penetration of flufenamic acid: in vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject.

Authors:  Heike Wagner; Karl-Heinz Kostka; Claus-Michael Lehr; Ulrich F Schaefer
Journal:  J Invest Dermatol       Date:  2002-03       Impact factor: 8.551

9.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

10.  A clinical study comparing the skin antisepsis and safety of ChloraPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine.

Authors:  John S Hibbard; Gayle K Mulberry; Ann R Brady
Journal:  J Infus Nurs       Date:  2002 Jul-Aug
View more
  14 in total

1.  Permeation of chlorhexidine from alcoholic and aqueous solutions within excised human skin.

Authors:  T J Karpanen; T Worthington; B R Conway; A C Hilton; T S J Elliott; P A Lambert
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

2.  Distribution and visualisation of chlorhexidine within the skin using ToF-SIMS: a potential platform for the design of more efficacious skin antiseptic formulations.

Authors:  Amy M Judd; David J Scurr; Jon R Heylings; Ka-Wai Wan; Gary P Moss
Journal:  Pharm Res       Date:  2013-05-01       Impact factor: 4.200

3.  GSK2646264, a spleen tyrosine kinase inhibitor, attenuates the release of histamine in ex vivo human skin.

Authors:  Cesar Ramirez Molina; Sidsel Falkencrone; Per S Skov; Edward Hooper-Greenhill; Mike Barker; Marion C Dickson
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

4.  Enhanced chlorhexidine skin penetration with eucalyptus oil.

Authors:  Tarja J Karpanen; Barbara R Conway; Tony Worthington; Anthony C Hilton; Tom S J Elliott; Peter A Lambert
Journal:  BMC Infect Dis       Date:  2010-09-22       Impact factor: 3.090

5.  Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use.

Authors:  Luiz Francisco Jones Soares da Silva; Flavia Almada do Carmo; Vinicius Raphael de Almeida Borges; Lidiane Mota Monteiro; Carlos Rangel Rodrigues; Lúcio Mendes Cabral; Valeria Pereira de Sousa
Journal:  Int J Nanomedicine       Date:  2011-06-03

6.  New materials and devices for preventing catheter-related infections.

Authors:  Jean-François Timsit; Yohann Dubois; Clémence Minet; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Rebecca Hamidfar-Roy; Carole Schwebel
Journal:  Ann Intensive Care       Date:  2011-08-18       Impact factor: 6.925

Review 7.  Use of Chlorhexidine Preparations in Total Joint Arthroplasty.

Authors:  Jaiben George; Alison K Klika; Carlos A Higuera
Journal:  J Bone Jt Infect       Date:  2017-01-01

8.  Investigation of Effect of 1,8-cineole on Antimicrobial Activity of Chlorhexidine Gluconate.

Authors:  Merih Şimşek; Reşat Duman
Journal:  Pharmacognosy Res       Date:  2017 Jul-Sep

9.  Antimicrobial efficacy of a novel eucalyptus oil, chlorhexidine digluconate and isopropyl alcohol biocide formulation.

Authors:  Emma Hendry; Barbara Conway; Tony Worthington
Journal:  Int J Mol Sci       Date:  2012-10-30       Impact factor: 5.923

10.  Prospective evaluation of 2% (w/v) alcoholic chlorhexidine gluconate as an antiseptic agent for blood donor arm preparation.

Authors:  Sweta Shah; Nidhi Ajay Mehta; Sweta Ganesh Jadhav
Journal:  Asian J Transfus Sci       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.